Real-Time check during biopsy could boost personalized lung cancer treatment

NCT ID NCT04945317

ENROLLING_BY_INVITATION Diagnosis Sponsor: Johns Hopkins University Source: ClinicalTrials.gov ↗

First seen Jan 04, 2026 · Last updated May 02, 2026 · Updated 15 times

Summary

This study compares two methods for collecting tissue samples during lung cancer biopsies. Researchers want to see if having a specialist check tissue quality immediately during the procedure helps collect enough material for advanced genetic testing. This genetic testing helps identify specific mutations that can guide personalized treatment options for patients with non-small cell lung cancer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER NSCLC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Johns Hopkins Bayview Medical Center

Baltimore, Maryland, 21224, United States
Johns Hopkins Hospital

Baltimore, Maryland, 21287, United States
Northwestern Medicine

Chicago, Illinois, 60611, United States
The Medical University of South Carolina (MUSC)

Charleston, South Carolina, 29425, United States

Conditions

Explore the condition pages connected to this study.

NON SMALL CELL LUNG CANCER NSCLC NON-SMALL CELL LUNG CANCER (NSCLC)